학술논문
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Document Type
Article
Author
Source
In: Blood Cancer Journal . (Blood Cancer Journal, 1 January 2018, 8(1))
Subject
Language
English
ISSN
20445385